Lilly, Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns. - Barron's
1. LLY and NVO dominate the U.S. weight-loss drug market. 2. Morningstar predicts a $200 billion market by 2031 for weight-loss drugs. 3. Goldman Sachs lowered its market estimate to $95 billion by 2030. 4. Several competitors are emerging in the weight-loss drug sector. 5. Amgen's MariTide shows promise but faces dropouts due to side effects.